For enrichment only (not for CEUs)

Thank you Katie McBee, PT, DPT, OCS, MS, CEAS II, PYT-C for your help in developing and authoring this quiz.

REFERENCE:
Cibulka MT, Bloom NJ, Enseki KR, Macdonald CW, Woehrle J, McDonough CM. Hip Pain and Mobility Deficits—Hip Osteoarthritis: Revision 2017; J Orthop Sports Phys Ther. 2017 Jun;47(6):A1-A37
https://www.jospt.org/doi/full/10.2519/jospt.2017.0301?code=jospt-site  

https://www.orthopt.org/content/practice/clinical-practice-guidelines

Question Title

* 1. The following are included as criteria to classify adults over the age of 50 years into the ICF category of hip pain and mobility deficits.

Question Title

* 2. Which of the following activity limitation and participation restriction outcome measures is recommended in AOPT's Hip OA Clinical Practice Guideine:

Question Title

* 3. There is significant evidence to support the use of injectable viscosupplementation of hyaluronic acid into the hip joints of patients with hip OA.

Question Title

* 4. The dose recommendation for manual therapy for hip OA and impaired mobility is:

Question Title

* 5. Modalities are not recommended by the Hip OA CPG for the long term physical therapy management of Hip OA.

0 of 5 answered
 

T